Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR
Chimeric antigen receptor (CAR)-modified T cells targeting CD19 demonstrate unparalleled
responses in relapsed/refractory acute lymphoblastic leukemia (ALL) 1 , 2 , 3 , 4 – 5 , but …
responses in relapsed/refractory acute lymphoblastic leukemia (ALL) 1 , 2 , 3 , 4 – 5 , but …
[HTML][HTML] CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a …
Chimeric antigen receptor (CAR) T cells targeting CD19 or CD22 have shown remarkable
activity in B cell acute lymphoblastic leukemia (B-ALL). The major cause of treatment failure is …
activity in B cell acute lymphoblastic leukemia (B-ALL). The major cause of treatment failure is …
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
…, MF Wu, RJ Rochester, PJ Amrolia… - Blood, The Journal …, 2010 - ashpublications.org
T-cell immunotherapy that takes advantage of Epstein-Barr virus (EBV)–stimulated immunity
has the potential to fill an important niche in targeted therapy for EBV-related cancers. To …
has the potential to fill an important niche in targeted therapy for EBV-related cancers. To …
Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation
PJ Amrolia, G Muccioli-Casadei, H Huls, S Adams… - Blood, 2006 - ashpublications.org
Poor T lymphocyte reconstitution limits the use of haploidentical stem cell transplantation (SCT)
because it results in a high mortality from viral infections. One approach to overcome this …
because it results in a high mortality from viral infections. One approach to overcome this …
Clonal expansion of T memory stem cells determines early anti-leukemic responses and long-term CAR T cell persistence in patients
…, B Popova, A Lopes, M Pule, AJ Thrasher, PJ Amrolia - Nature cancer, 2021 - nature.com
Low-affinity CD19 chimeric antigen receptor (CAR) T cells display enhanced expansion and
persistence, enabling fate tracking through integration site analysis. Here we show that …
persistence, enabling fate tracking through integration site analysis. Here we show that …
Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?
…, P Taupin, AJ Cant, P Veys, PJ Amrolia… - Journal of allergy and …, 2010 - Elsevier
BACKGROUND: Hematopoietic stem cell transplantation remains the only treatment for
most patients with severe combined immunodeficiencies (SCIDs) or other primary …
most patients with severe combined immunodeficiencies (SCIDs) or other primary …
[HTML][HTML] Betibeglogene Autotemcel Gene Therapy for Non–β0/β0 Genotype β-Thalassemia
…, TS Olson, B Carpenter, PJ Amrolia… - … England Journal of …, 2022 - Mass Medical Soc
Background Betibeglogene autotemcel (beti-cel) gene therapy for transfusion-dependent β-thalassemia
contains autologous CD34+ hematopoietic stem cells and progenitor cells …
contains autologous CD34+ hematopoietic stem cells and progenitor cells …
[HTML][HTML] Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemia
In the context of relapsed and refractory childhood pre-B cell acute lymphoblastic leukemia (R/R
B-ALL), CD19-targeting chimeric antigen receptor (CAR)-T cells often induce durable …
B-ALL), CD19-targeting chimeric antigen receptor (CAR)-T cells often induce durable …
Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses
PJ Amrolia, G Muccioli-Casadei, E Yvon, H Huls, U Sili… - Blood, 2003 - ashpublications.org
Poor immune reconstitution after haploidentical stem cell transplantation results in a high
mortality from viral infections and relapse. One approach to overcome this problem is to …
mortality from viral infections and relapse. One approach to overcome this problem is to …
Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen
K Rao, PJ Amrolia, A Jones, CM Cale, P Naik, D King… - Blood, 2005 - ashpublications.org
The optimal approach to stem cell transplantation in children with immunodeficiency who
lack a matched family donor is controversial. Unrelated donor stem cell transplantation gives …
lack a matched family donor is controversial. Unrelated donor stem cell transplantation gives …
